Astrego Diagnostics

About this entry

Astrego Diagnostics is founded on technology originally developed for fundamental research on bacterial growth at the level of single cells and sensitive bacterial imaging. It was however realized that this technology, in its simplest form, also had the potential to be used for very fast antibiotic susceptibility testing.

Astrego Diagnostics’ Antibiotic Susceptibility Testing (AST) technology is based on cutting edge microfluidics and time-resolved imaging to monitor bacterial growth in the patient sample – in real-time. Thus, the AST test is truly phenotypic, the result being dependent on the characteristics of the bacteria present. The unique microfluidic setup allows the fastest possible results, only limited by the biological response to the tested antibiotics (<30 min).

Astrego Diagnostics consist of a dedicated team of experienced engineers with the necessary competences to develop the technology concept into a commercial product. The primary focus is to develop a cheap, easy-to-use, point-of-care test for antibiotic resistance in urinary tract infection – the qUTI system. The qUTI system will change the empirical management paradigm for UTI, providing patients with effective antibiotic prescriptions at their first consultation.

If you would like to be introduced to this team for collaboration, get in touch with the Longitude prize.